Neovascular Age Related Macular Degeneration Clinical Trial
Background: To identify characteristic morphological changes of the retina, their change
over time and the association with visual function after combined photodynamic therapy (PDT)
and intravitreal triamcinolone (IVTA).
Methods: In this retrospective study, 40 patients (40 eyes) were treated with PDT and same
day IVTA. Optical coherence tomography (OCT), fluorescein angiography (FA) and evaluation of
distance visual acuity (VA) were performed. Main outcome measures were the anatomical
changes within intra- and subretinal compartments and their detailed analysis and grading.
n/a
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02251366 -
NVAMD Satellite Study
|
N/A | |
| Unknown status |
NCT00767949 -
Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration
|
Phase 1 | |
| Completed |
NCT00764738 -
Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
|
Phase 2/Phase 3 | |
| Completed |
NCT00383370 -
Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
|
Phase 1 | |
| Completed |
NCT01678963 -
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
|
Phase 2 | |
| Completed |
NCT03930641 -
Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
|
Phase 3 | |
| Completed |
NCT01863199 -
Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)
|
Phase 4 | |
| Recruiting |
NCT05562947 -
A Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Chinese Patients With Neovascular Age-Related Macular Degeneration
|
Phase 3 | |
| Completed |
NCT04239027 -
A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration
|
Phase 3 | |
| Completed |
NCT00574093 -
Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD
|
Phase 2 | |
| Completed |
NCT01942213 -
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
|
N/A | |
| Recruiting |
NCT00640640 -
The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)
|
N/A |